Nav: Home

Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths

May 01, 2016

Turin, Italy: Researchers have found that treating patients who have early stage non-small cell lung cancer (NSCLC) with a type of radiotherapy called stereotactic body radiation therapy (SBRT) is associated with a small but increased risk of death from causes other than cancer.

In particular, they found that high doses to the left atrium of the heart and the superior vena cava (the large vein carrying deoxygenated blood from the head, arms and upper body to the heart) had the strongest association and increased risk of non-cancer death.

Dr Barbara Stam (PhD), from the Netherlands Cancer Institute (Amsterdam, The Netherlands) told the ESTRO 35 conference today (Monday) that, as a result of these findings, she and other researchers would be investigating ways to deliver radiotherapy while sparing these crucial heart structures as much as possible.

"Our results show that even within a few years a radiation dose to the heart is associated with an increased risk of non-cancer death for early stage lung cancer patients, and they indicate which regions of the heart possibly play a role. Validation and further investigations into the exact mechanisms and which heart structures are critical is warranted, but clinically, this could mean that patients might benefit from heart-sparing radiotherapy. For early stage lung cancer patients, treated with SBRT, we still need to investigate if heart sparing is possible, what compromises need to be made and whether it can increase survival. Further research and a wider discussion on heart sparing at the cost of possibly a higher average lung doses is required," she told the conference.

Dr Stam and colleagues analysed data from 565 patients diagnosed with early NSCLC between 2006-2013 in five institutions in Europe and North America [1], who were treated with SBRT. SBRT is a specialised type of external beam radiation therapy that can focus radiation beams with extreme accuracy on a tumour, thereby minimising the effect on nearby organs. With multiple organs nearby, minimising the dose to one organ is likely to result in a higher dose in another organ.

In order to work out how much radiation was delivered to which sub-structures of the heart, the researchers created a "template" image of the heart and its sub-structures on to which they could map the anatomy of each of the 565 patients -- a process called deformable image registration. Information on the radiation doses for the patients was added, and this enabled the researchers to work out the dose parameters (such as minimum, average and maximum doses) for the various parts of the heart such as the right and left atria, right and left ventricles, superior vena cava, descending aorta and left pulmonary artery.

"Then we determined the association between these dose parameters and non-cancer death for each sub-structure and for each dose parameter," said Dr Stam. "Finding if there is a relation between dose to sub-structures and non-cancer death is only relevant if this relation still exists when other factors that are known to be related to non-cancer death are also taken into account. Therefore, we performed a second statistical analysis, including factors such as age, lung function and performance status."

After a median (average) follow-up of 28 months, 58% of the patients were still alive. "We found that dose to all sub-structures of the heart were associated with non-cancer death for this group of patients. Two sub-structures had the strongest association with non-cancer death: the maximum dose on the left atrium and the dose to a small area of the superior vena cava. Patients with low doses on the left atrium combined with low doses on the superior vena cava have a higher chance of survival than patients with high doses on the left atrium combined with high doses on the superior vena cava. This association remained after adjustments for the factors included in the second analysis," she said.

The associations between higher radiation doses to the left atrium and the superior vena cava and deaths from causes other than cancer were small but significant for the investigated patient group: in the left atrium, for every 1Gy above the average dose of 7.9Gy the risk increased by 1.5%, while for other structures the risk increased by between 1-2%.

The researchers do not know what were the causes of the non-cancer deaths as these lung cancer patients were already elderly (on average of 73 years old) and usually died at home with no autopsies being performed. However, it's hypothesised that the deaths were related to heart problems, as research in breast cancer patients, who have a much longer life expectancy than lung cancer patients, has shown that radiotherapy can affect the heart adversely.

President of ESTRO, Professor Philip Poortmans, who was not involved in the research, commented: "This study confirms that we should take the dose to organs at risk into consideration, not only for malignant lymphoma and breast cancer patients, who are in general younger and have a much longer life expectancy, but also for lung cancer patients when cure is an option. The complex interaction between dose to the heart and comorbidity and age and its influence on non-cancer related death remains to be explored in further detail as the excess death rate is seen starting a very short time after treatment, in contrast to the data in lymphoma and breast patients. Research into the details of the dose distribution and the (largely unknown) causes of death is required before these results could be translated to the daily clinics' environment -- apart from the advice to keep the dose to the heart as low as possible while maintaining optimal tumour control."
-end-


European Society for Radiotherapy and Oncology (ESTRO)

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.